Be part of the knowledge - Eye Health Academy

Medical News

medicalxpress.com
03/23/2023
Medical News
'Biohybrid' Device Could Restore Function in Paralyzed Limbs
Read more
bmj.com
03/22/2023
Medical News
Networks of Care to Strengthen Primary Healthcare in Resource Constrained Setti…
Read more
cbsnews.com
03/22/2023
Medical News
What Research Shows About Risks of Myocarditis from COVID Vaccines Versus Risks…
Read more

Popular

- Christina Y. Weng, MD, MBA
  Peer
- Glenn Yiu, MD, PhD
  Peer
0
CME/CE
Diabetic Eye Disease Pipeline Therapies Part 2: High-dose Aflibercept & Gene Therapy
Diabetic Eye Disease Pipeline Therapies Part 2: High-dose Aflibercept & Gene Therapy
0.50 credits
Diabetic Eye Disease Pipeline Therapies Part 2: High-dose Aflibercept & Gen…
0.50 credits
- Christina Y. Weng, MD, MBA
  Peer
- Basil K. Williams Jr, MD
  Peer
0
CME/CE
Wet AMD Pipeline Therapies Part 3: KSI-301 and GB-102
Wet AMD Pipeline Therapies Part 3: KSI-301 and GB-102
0.50 credits
Wet AMD Pipeline Therapies Part 3: KSI-301 and GB-102
0.50 credits
- Christina Y. Weng, MD, MBA
  Peer
- Peter A. Campochiaro, MD
  Peer
1
CME/CE
Wet AMD Pipeline Therapies Part 2: PDS and RGX-314
Wet AMD Pipeline Therapies Part 2: PDS and RGX-314
0.75 credits
Wet AMD Pipeline Therapies Part 2: PDS and RGX-314
0.75 credits
- David Eichenbaum, MD
  Peer
- Mark R. Barakat, MD
  Peer
2
CME/CE
Retina Clinic: Current Treatment Options in DME
Retina Clinic: Current Treatment Options in DME
0.25 credits
Retina Clinic: Current Treatment Options in DME
0.25 credits
- John Kitchens, MD
  Peer
- SriniVas R. Sadda, MD
  Peer
4
CME/CE
The Future Is Now: A Closer Look at Implantable Anti-VEGF Technology
The Future Is Now: A Closer Look at Implantable Anti-VEGF Technology
0.25 credits
The Future Is Now: A Closer Look at Implantable Anti-VEGF Technology
0.25 credits
- Avni P. Finn, MD, MBA
  Peer
- Jayanth Sridhar, MD
  Peer
2
CME/CE
New Perspectives on Managing Diabetic Retinopathy
New Perspectives on Managing Diabetic Retinopathy
0.25 credits
New Perspectives on Managing Diabetic Retinopathy
0.25 credits
- Susan B. Bressler, MD
  Peer
- Mark Dunbar, OD, FAAO
  Peer
- Ruth S. Weinstock, MD, PhD
  Peer
1
CME/CE
Saving Sight in Your Patients with Diabetes: What You Might Be Missing
Saving Sight in Your Patients with Diabetes: What You Might Be Missing
0.25 credits
Saving Sight in Your Patients with Diabetes: What You Might Be Missing
0.25 credits
- Carolyn E. Majcher, OD, FAAO
  Peer
- Diana Shechtman, OD, FAAO
  Peer
2
CME/CE
New Strategies for Managing Diabetic Retinopathy
New Strategies for Managing Diabetic Retinopathy
0.25 credits
New Strategies for Managing Diabetic Retinopathy
0.25 credits

Clinical Practice

- Christina Y. Weng, MD, MBA
  Peer
- David Eichenbaum, MD
  Peer
1
CME/CE
Diabetic Eye Disease Pipeline Therapies Part 1: Faricimab, KSI-301, and OPT-302
Diabetic Eye Disease Pipeline Therapies Part 1: Faricimab, KSI-301, and OPT-302
0.50 credits
Diabetic Eye Disease Pipeline Therapies Part 1: Faricimab, KSI-301, and OPT-302
0.50 credits
- Christina Y. Weng, MD, MBA
  Peer
- Sophie J. Bakri, MD
  Peer
1
CME/CE
Diabetic Eye Disease Pipeline Therapies Part 3: Brolucizumab & PDS
Diabetic Eye Disease Pipeline Therapies Part 3: Brolucizumab & PDS
0.50 credits
Diabetic Eye Disease Pipeline Therapies Part 3: Brolucizumab & PDS
0.50 credits
- Christina Y. Weng, MD, MBA
  Peer
- Diana Do, MD
  Peer
0
CME/CE
Wet AMD: Pipeline Therapies Part 1 - Faricimab and OPT-302
Wet AMD: Pipeline Therapies Part 1 - Faricimab and OPT-302
0.50 credits
Wet AMD: Pipeline Therapies Part 1 - Faricimab and OPT-302
0.50 credits
- Jillian Ziemanski, OD, PhD, FAAO
  Peer
- Cynthia Matossian, MD, FACS
  Peer
2
CME/CE
Improving Meibomian Gland Dysfunction with Device Management
Improving Meibomian Gland Dysfunction with Device Management
0.25 credits
Improving Meibomian Gland Dysfunction with Device Management
0.25 credits
- Roger A. Goldberg, MD
  Peer
- Peter A. Campochiaro, MD
  Peer
2
CME/CE
Retina Clinic: Emerging Treatment Options in Diabetic Retinopathy
Retina Clinic: Emerging Treatment Options in Diabetic Retinopathy
0.25 credits
Retina Clinic: Emerging Treatment Options in Diabetic Retinopathy
0.25 credits
- J. Fernando Arevalo, MD, PhD
  Peer
- W. Lloyd Clark, MD
  Peer
4
CME/CE
The Future Is Now: Latest Surgical Techniques for Anti-VEGF Delivery
The Future Is Now: Latest Surgical Techniques for Anti-VEGF Delivery
0.25 credits
The Future Is Now: Latest Surgical Techniques for Anti-VEGF Delivery
0.25 credits
- Diana Shechtman, OD, FAAO
  Peer
2
NEI Blindness Prevention Initiative
Patient Education: A Lifetime of Vision
Patient Education: A Lifetime of Vision
Patient Education: A Lifetime of Vision
1
NEI Blindness Prevention Initiative
Do You See What I See?
Do You See What I See?
Do You See What I See?